Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure

Ann Hematol. 2015 Mar;94(3):501-3. doi: 10.1007/s00277-014-2174-1. Epub 2014 Aug 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / adverse effects
  • Arsenic Trioxide
  • Arsenicals* / administration & dosage
  • Arsenicals* / adverse effects
  • Heart Failure / complications*
  • Humans
  • Leukemia, Promyelocytic, Acute / complications*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Oxides* / administration & dosage
  • Oxides* / adverse effects
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / diagnosis

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic Trioxide